Steve Decesare, Sharon Xuereb and Maria Grima have contributed the Maltese chapter for Trademarks 2020, published by Lexology.
Members of our pharmaceutical and healthcare team recently attended the Medical Cannabiz World Summit held on the 4 and 5 November 2019 in Malta.
On 2 October 2019, the European Securities and Markets Authority (“ESMA”) issued an update of its Q&A on practical questions regarding data reporting issues, stemming from the European Markets Infrastructure Regulation (“EMIR”).
On 3 October 2019, the European and Securities Markets Authority (ESMA) published an updated version of its Q&As on investor protection and intermediaries topics under Markets in Financial Instruments Directive (“MiFID II”) and Markets in Financial Instruments Regulation.
On 4 October 2019, the European Securities and Markets Authority (“ESMA”) launched a consultation paper on possible amendments to the trading obligation under the Markets in Financial Instruments Regulation (“MiFIR”), following the introduction of the EMIR Refit Regulation (“EMIR Refit”).
In July 2019, the so-called ‘AIFMD 2’ - Directive (EU) 2019/1160 amending Directives 2009/65/EC and 2011/61/EU with regard to cross-border distribution of collective investment undertakings (the “Directive”) entered into force.